TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Detecting endometrial cancer

Key Statistics

  • 9000+ — New UK EC cases/year
  • 90% — EC presents with PMB
  • ≥4–5 mm — BGCS TVS thickness cut-off

Don't-miss facts

  1. PMB = bleeding >12 months after menopause; >90% of EC presents with PMB, but >90% of PMB is benign

  2. NICE NG12: 2WW referral for PMB ≥55 years (consider if <55); refer HRT-associated unscheduled bleeding if >6 months, or new PMB persisting >6 weeks after stopping HRT

  3. BGCS pathway: TVS first-line → endometrial biopsy ± hysteroscopy if endometrium thickened (cut-off ≥4–5 mm)

  4. Pipelle biopsy failure 11%, inadequate sample 31% – 4.5% of "inadequate" samples were later EC, so do not falsely reassure

  5. Hysteroscopy: sensitivity 86.4%, specificity 99.2%; Cochrane review shows no proven analgesic benefit from opioids/local anaesthetic at outpatient hysteroscopy – offer GA option and vaginoscopic technique

  6. Every 5 kg/m² BMI rise → 50% ↑EC risk; Lynch syndrome → 25–60% lifetime risk (annual TVS/hysteroscopy/biopsy from age 35 per BGCS)

  7. Tamoxifen: 3× ↑EC risk but also causes false-positive TVS appearances (stromal hypertrophy)

  8. No UK EC screening programme exists; novel non-invasive detection tools (urine, blood, vaginal self-sampling) remain investigational, unvalidated

TVS thickness cut-offs (sens/spec)

≥4mm: 95.7% / 46.0% ≥5mm: 96.2% / 51.5% ≥10mm: 78.2% / 83.7% ≥15mm: 58.9% / 94.2%

Abbreviation Key

  • EC — endometrial cancer
  • NPV — negative predictive value
  • PMB — postmenopausal bleeding
  • 2WW — two-week wait
  • TVS — transvaginal sonography/ultrasound scan
  • MRI — magnetic resonance imaging
  • NICE — National Institute for Health and Care Excellence
  • CT — computed tomography
  • BGCS — British Gynaecological Cancer Society
  • NSAID — nonsteroidal anti-inflammatory drug
  • SIGN — Scottish Intercollegiate Guidelines Network
  • UKCTOCS — UK Collaborative Trial of Ovarian Cancer Screening
  • RCOG — Royal College of Obstetricians and Gynaecologists
  • HPV — human papillomavirus
  • BMI — body mass index
  • CA125 — cancer antigen 125
  • PCOS — polycystic ovary syndrome
  • HE4 — human epididymis protein 4
  • HRT — hormone replacement therapy
  • CTC — circulating tumour cell
  • AEH — atypical endometrial hyperplasia
  • ctDNA — circulating tumour DNA
  • CI — confidence interval
  • miRNA — microRNA

Source: Jones ER et al. Detecting endometrial cancer. The Obstetrician & Gynaecologist 2021;23:103–112. doi:10.1111/tog.12722

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free